Lupin receives USFDA approval for Dapagliflozin and Metformin Hydrochloride XR Tablets

Lupin receives USFDA approval for Dapagliflozin and Metformin Hydrochloride XR Tablets


Lupin today announced that it has received approval from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug Application for Dapagliflozin and Metformin Hydrochloride Extended-Release Tablets, 5 mg/500 mg, 5 mg/1,000 mg, 10 mg/500 mg, 10 mg/1,000 mg. The company also received tentative approval for Dapagliflozin and Metformin Hydrochloride Extended-Release Tablets, 2.5 mg/1,000 mg.

The U.S. FDA has approved Lupin’s Dapagliflozin and Metformin Hydrochloride Extended-Release Tablets as bioequivalent to Xigduo XR for the indications in the approved labeling.

 

Disclaimer: No Business Standard Journalist was involved in creation of this content

First Published: Apr 08 2026 | 7:31 PM IST



Source link

Lupin receives USFDA approval for Dapagliflozin and Metformin Hydrochloride XR Tablets

NTPC signs MoU with ectricite de France


To collaborate on nuclear power projects in India

NTPC has signed a Non-Binding Memorandum of Understanding (MoU) with ectricitde France (EDF) to explore cooperation in developing new nuclear power projects in India. This follows approval from the concerned ministries & departments of the Government of India.

The MoU establishes a framework for both companies to jointly assess the feasibility and approach for collaboration, including understanding EDF’s EPR technology and its suitability for Indian requirements, exploring opportunities to maximize localization for large-scale deployment, examining economic and tariff aspects, developing human resource capabilities through training programmes, evaluating potential project sites, and providing technical support as mutually agreed.

 

Disclaimer: No Business Standard Journalist was involved in creation of this content

First Published: Apr 08 2026 | 7:31 PM IST



Source link

Lupin receives USFDA approval for Dapagliflozin and Metformin Hydrochloride XR Tablets

Cabinet approves Nutrient Based Subsidy (NBS) rates for coming Kharif Season


The Union Cabinet has approved proposal of the Department of Fertilizers for fixing the Nutrient Based Subsidy (NBS) rates for KHARIF Season, 2026 (from 01.04.2026 to 30.09.2026) on Phosphatic and Potassic (P&K) fertilizers. The tentative budgetary requirement for Kharif season 2026 would be approximately Rs.41,533.81 crore. This is approximate Rs. 4,317 crore more than the budgetary requirement for Kharif 2025 season. The budget for Kharif 2025 was Rs.37,216.15 crore. Following this, availability of fertilizers to farmers at subsidized, affordable and reasonable prices will be ensured. The subsidy on P&K fertilizers including DAP and NPKS grades will be provided based on approved rates for Kharif 2026 (applicable from 01.04.2026 to 30.09.2026) to ensure smooth availability of these fertilizers to the farmers at affordable prices.
 

Disclaimer: No Business Standard Journalist was involved in creation of this content

First Published: Apr 08 2026 | 6:04 PM IST



Source link

Lupin receives USFDA approval for Dapagliflozin and Metformin Hydrochloride XR Tablets

Urban consumer confidence deteriorated, says RBI


The Reserve Bank of India has released the results of March 2026 round of its bi-monthly urban consumer confidence survey (UCCS). The survey was conducted during February 25 to March 10, 2026, covering 6069 respondents across 19 major cities. Consumer confidence for the current period deteriorated in the pessimistic zone with the Current Situation Index (CSI) at 95.7 against 98.1 in the previous round. Confidence for the year ahead, though optimistic, also saw a decline from the previous round. The Future Expectations Index (FEI) dropped by 3.2 points to 120.2. Households current perception on economic situation ebbed for the second consecutive round, registering a decrease of 5.1 points from the previous round. The outlook also declined by 6.2 points, though remained in the optimistic zone. The current perception and year-ahead expectation of households on employment situation have worsened by 2.8 and 7.8 points, respectively.
 

Disclaimer: No Business Standard Journalist was involved in creation of this content

First Published: Apr 08 2026 | 6:04 PM IST



Source link

Lupin receives USFDA approval for Dapagliflozin and Metformin Hydrochloride XR Tablets

INR rebounds well as oil prices tumble sharply; RBI keeps repo rate unchanged


The Indian rupee appreciated well on Wednesday tracking sharp weakness in dollar overseas following a sharp plunge in international oil prices after US and Iran agreed on a two-weak ceasefire. Trump announced that he would suspend planned military strikes against Iran for two weeks, subject to Tehran agreeing to fully reopen the Strait of Hormuz. INR jumped to a three week high and hit a high of Rs 92.45 per dollar during intraday moves. The domestic currency ended the day at 92.55, up 51 paise as compared to previous close at 93.06. Meanwhile, the Reserve Bank of Indias (RBIs) Monetary Policy Committee (MPC) decided to keep policy repo rate unchanged at 5.25% while announcing its first policy decision of FY27. High frequency indicators till February 2026 suggest the continuation of strong momentum in economic activity, RBI stated in its monetary policy report. Growth impulses continue to be supported by robust private consumption and investment demand. However, the West Asia conflict will adversely impact growth, RBI noted. Higher input costs associated with increase in energy prices and international freight and insurance costs along with supply-chain disruptions could constrain availability of key inputs for downstream sectors, thus impairing growth.

 

Disclaimer: No Business Standard Journalist was involved in creation of this content

First Published: Apr 08 2026 | 5:31 PM IST



Source link

Lupin receives USFDA approval for Dapagliflozin and Metformin Hydrochloride XR Tablets

Pound zooms to two-week high against US dollar, FTSE100 spikes around 3%


UK Pound spiked today as the US dollar tumbled following indications from Donald Trump of a temporary pause in hostilities with Iran. Risk appetite surged and UK stocks zoomed. The FTSE 100 index zoomed around 3% as Brent crude futures tumbled nearly 14% on the day. GBP/USD pair jumped 1.34% at 1.3433 hitting two-week top as the US dollar index slipped sharply. On NSE, GBP/INR futures are up 0.93% at 124.98. It managed to hit above 125 mark earlier in the session.
 

Disclaimer: No Business Standard Journalist was involved in creation of this content

First Published: Apr 08 2026 | 4:31 PM IST



Source link

YouTube
Instagram
WhatsApp